Cargando…
Thermoresponsive Polypeptide Fused L‐Asparaginase with Mitigated Immunogenicity and Enhanced Efficacy in Treating Hematologic Malignancies
L‐Asparaginase (ASP) is well‐known for its excellent efficacy in treating hematological malignancies. Unfortunately, the intrinsic shortcomings of ASP, namely high immunogenicity, severe toxicity, short half‐life, and poor stability, restrict its clinical usage. Poly(ethylene glycol) conjugation (PE...
Autores principales: | Zhang, Sanke, Sun, Yuanzi, Zhang, Longshuai, Zhang, Fan, Gao, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427413/ https://www.ncbi.nlm.nih.gov/pubmed/37271878 http://dx.doi.org/10.1002/advs.202300469 |
Ejemplares similares
-
Immunogenic Cell Death in Hematological Malignancy Therapy
por: Liu, Zhaoyun, et al.
Publicado: (2023) -
Thermoresponsive and Protease‐Cleavable Interferon‐Polypeptide Conjugates with Spatiotemporally Programmed Two‐Step Release Kinetics for Tumor Therapy
por: Wang, Zhuoran, et al.
Publicado: (2019) -
Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer
por: Liang, Ai-Ling, et al.
Publicado: (2015) -
Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases
por: Pokrovsky, Vadim S., et al.
Publicado: (2016) -
Physicochemical
Characterization of a Biomimetic,
Elastin-Inspired Polypeptide with Enhanced Thermoresponsive Properties
and Improved Cell Adhesion
por: Bandiera, Antonella, et al.
Publicado: (2023)